We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Colgate-Palmolive
CL
$72.6B
| $467K | 0.01% |
6,300
-830
| -12% | -$61.4K |
|
727
Innospec
IOSP
$2.09B
| $467K | 0.01% |
7,675
-13,909
| -64% | -$774K |
|
|
CTRA
728
DELISTED
Coterra Energy
CTRA
| $462K | 0.01% |
+17,920
| New | +$448K |
|
|
QHC
729
DELISTED
Quorum Health Corporation
QHC
| $460K | 0.01% |
73,433
-49,233
| -40% | -$404K |
|
|
SGBK
730
DELISTED
Stonegate Bank
SGBK
| $458K | 0.01% |
13,580
+100
| +0.7% | +$3.23K |
|
|
IO
731
DELISTED
ION Geophysical Corporation
IO
| $458K | 0.01% |
66,849
+16,726
| +33% | +$96.5K |
|
732
LivePerson
LPSN
$18.9M
| $457K | 0.01% |
3,624
+1,120
| +45% | +$128K |
|
733
Steel Dynamics
STLD
$35.6B
| $447K | 0.01% |
+17,900
| New | +$457K |
|
|
ITG
734
DELISTED
Investment Technology Group Inc
ITG
| $446K | 0.01% |
26,038
+1,500
| +6% | +$24.8K |
|
735
PC Connection
CNXN
$2.05B
| $445K | 0.01% |
16,830
-1,350
| -7% | -$34.5K |
|
|
HA
736
DELISTED
Hawaiian Holdings, Inc.
HA
| $445K | 0.01% |
9,160
-4,160
| -31% | -$189K |
|
737
Pixelworks
PXLW
$38.8M
| $444K | 0.01% |
13,257
-2,267
| -15% | -$68.3K |
|
|
FDML
738
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $444K | 0.01% |
46,250
| – | – |
|
|
AFAM
739
DELISTED
Almost Family Inc
AFAM
| $443K | 0.01% |
12,040
| – | – |
|
|
ATYR
740
aTyr Pharma
ATYR
$46.4M
| $442K | 0.01% |
9,926
+6,330
| +176% | +$274K |
|
|
SEMG
741
DELISTED
SEMGROUP CORPORATION
SEMG
| $438K | 0.01% |
12,386
-112,045
| -90% | -$3.56M |
|
742
ArcBest
ARCB
$3.44B
| $434K | 0.01% |
22,820
| – | – |
|
|
EXAC
743
DELISTED
Exactech Inc
EXAC
| $434K | 0.01% |
16,049
| – | – |
|
|
XRM
744
DELISTED
Xerium Technologies Inc (new)
XRM
| $426K | 0.01% |
+53,598
| New | +$427K |
|
745
Alpha and Omega Semiconductor
AOSL
$923M
| $423K | 0.01% |
19,479
-2,162
| -10% | -$38.8K |
|
746
Ducommun
DCO
$2.68B
| $423K | 0.01% |
18,519
+4,819
| +35% | +$103K |
|
|
FLOW
747
DELISTED
SPX FLOW, Inc.
FLOW
| $422K | 0.01% |
13,650
| – | – |
|
748
Western Alliance Bancorporation
WAL
$9.07B
| $416K | 0.01% |
11,080
-42,190
| -79% | -$1.5M |
|
749
Evercore
EVR
$13.1B
| $415K | 0.01% |
+8,060
| New | +$405K |
|
750
J&J Snack Foods
JJSF
$1.43B
| $410K | 0.01% |
3,440
-13,590
| -80% | -$1.64M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.